• Thu, April 5, 2018
  • Wed, April 4, 2018

Kennen MacKay Downgraded (ANAB) to Hold on, Apr 4th, 2018

Kennen MacKay of RBC Capital, Downgraded "AnaptysBio, Inc." (ANAB) to Hold on, Apr 4th, 2018.

Kennen has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with Kennen's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Kennen


  • Alex Schwartz of "Stifel" Maintained at Strong Buy with Increased Target to $152 on, Tuesday, March 27th, 2018
  • David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $151 on, Tuesday, February 20th, 2018